Health guide · Dog · Hematological

Immune-mediated

hemolytic anemia (IMHA)

IMHA is a serious condition in which the dog's immune system destroys its own red blood cells. Without prompt treatment, it can be life-threatening. With appropriate management, remission is possible in many dogs.

Definition

What is IMHA?

Immune-mediated hemolytic anemia (IMHA), also called autoimmune hemolytic anemia, occurs when the immune system overreacts and destroys the dog's own red blood cells (RBCs) prematurely. The loss of RBCs reduces the body's ability to transport oxygen throughout the body, which can cause serious breathing difficulties and, without treatment, be life-threatening.

Primary / idiopathic IMHA

No identifiable cause. The immune system attacks red blood cells without a known external trigger. This is the most common form. May have a genetic component; certain breeds (Cocker Spaniels, Springer Spaniels, Poodles) are at higher risk.

Secondary IMHA: medications & vaccines

Certain medications or vaccinations alter the surface of red blood cells, triggering an exaggerated immune response. Dogs that have suffered from IMHA may be exempt from certain future vaccinations.

Secondary IMHA: infections & parasites

Bacterial, viral, or parasitic infections (tick-borne diseases, ehrlichiosis, babesiosis, etc.) can trigger or worsen IMHA by altering the surface of red blood cells.

Evans syndrome

Simultaneous combination of IMHA with immune-mediated thrombocytopenia (IMT): the immune system destroys both red blood cells and platelets. More guarded prognosis and more complex treatment.

A related condition, immune-mediated thrombocytopenia (IMT), occurs when the immune system attacks platelets. IMT and IMHA can coexist (Evans syndrome) or appear separately.

Clinical signs

Signs and symptoms

IMHA signs can appear suddenly or develop gradually over several days. The rate of progression is variable and rapid deterioration is possible, making prompt veterinary consultation essential when in doubt. Signs do not always appear in the order below: a severe hemolytic crisis can be the very first visible sign.

Mild presentation

Signals not to ignore

Mild to moderate weight loss
Intermittent vomiting and diarrhea
Fluctuating loss of appetite
Weakness, reduced activity, less interested in play
Dull, unkempt coat
Spontaneous bruising (if IMT is also present)

Moderate presentation

Consult your veterinarian

Jaundice (icterus): yellow gums and whites of eyes
Panting, rapid breathing
Collapse or marked exercise intolerance
Bloody diarrhea
Belly that may look or feel swollen or firmer (spleen and liver enlarging as they clear destroyed RBCs)

Severe presentation

Veterinary emergency

Trembling, profound weakness, extreme lethargy
Whimpering or vocalizing in pain
Dark-colored urine (bilirubinuria or hemoglobinuria)
Very pale or white mucous membranes
Seizures (rare, sign of severe hypoxia)

Emergency

When to seek immediate help?

IMHA can rapidly become a life-threatening emergency. Go immediately to a veterinarian or emergency clinic if you observe:

Respiratory distress: intense panting, difficulty breathing, mouth breathing
Bluish, very pale, or white gums or tongue (cyanosis or severe anemia)
Sudden collapse or inability to stand
Uncontrollable vomiting or bloody diarrhea
Intense pain: constant whimpering, very tense abdomen
Dark tea-colored urine or blood in the urine

Call the clinic : 514 223-1197 Find a 24/7 emergency

Outside our opening hours, go to an emergency veterinary center without delay.

IMHA is a medical emergency. The faster the intervention, the better the chance of survival. Do not wait: even one of these signs warrants immediate emergency care.

Diagnosis

How is the diagnosis made?

Diagnosis can be challenging. It relies on a combination of clinical signs, bloodwork, and a search for an underlying cause, which can itself be difficult to identify.

Clinical signs and bloodwork

Low hematocrit (moderate to severe anemia), usually with a bone marrow that responds by producing new red blood cells (regenerative anemia). There is frequently an elevated white blood cell count (inflammation), raised bilirubin with jaundice (the direct product of RBC destruction), and sometimes elevated liver enzymes (the liver short of oxygen because of the anemia). The presence of spherocytes on a blood smear is a characteristic sign of IMHA.

Confirmatory tests

Direct Coombs test to detect antibodies bound to red blood cells. Blood smear to visualize spherocytes and signs of hemolysis, sometimes complemented by a saline slide-agglutination test. These tests confirm the immune origin of RBC destruction.

Search for underlying causes

Serology for tick-borne diseases (ehrlichiosis, babesiosis, anaplasmosis). Abdominal ultrasound and chest X-ray to screen for tumors. Biopsies or advanced imaging (CT scan, MRI) based on initial results.

Treatment

Treatment and management

Treatment is based on immunosuppression to stop RBC destruction, emergency stabilization when anemia is severe, and management of any identified underlying cause.

Immunosuppression

Corticosteroids (prednisone): the cornerstone of treatment: suppress the immune attack on RBCs. High initial doses, then gradual tapering over several months.
Other immunosuppressants: azathioprine, cyclosporine, or mycophenolate mofetil. In moderate to severe cases a second immunosuppressant is often started right away, together with the cortisone; in milder cases it is added only if the response to corticosteroids alone is insufficient.
Duration: several months of immunosuppressive treatment with gradual dose reduction once the condition stabilizes.

Emergency & supportive care

Blood transfusions: whole blood or packed red blood cells for life-threatening severe anemia: stabilizes the dog while immunosuppressants take effect.
Clot prevention: thrombosis (including pulmonary embolism) is one of the leading causes of death in IMHA. A preventive medication is therefore prescribed for nearly every affected dog: an anticoagulant (heparin), often favored in the first two weeks, or an antiplatelet, with clopidogrel preferred over low-dose aspirin.
Supportive care: antacids or gastroprotectants (against steroid-induced hyperacidity), liver support and probiotics as needed.

Underlying cause & follow-up

Treating the cause: if a tumor, infection, or triggering medication is identified, prompt management can significantly improve IMHA outcomes.
Regular monitoring: frequent bloodwork to monitor hematocrit, platelet count, and immunosuppressant side effects.
Vaccine exemption: dogs in remission may benefit from a veterinary exemption letter to avoid vaccinations that could trigger a relapse.

Prognosis

What to expect long-term?

Short-term prognosis depends primarily on speed of response to treatment and severity of anemia. The first two weeks are critical.

If the dog responds positively to treatment within 7–10 days, the outlook improves significantly and prolonged remission is possible.

Identifying and eliminating a treatable secondary cause (resectable tumor, infection) can considerably improve prognosis.

Even with intensive treatment, roughly 25 to 35% of dogs (1 in 4 to 1 in 3) may not survive the first few weeks, mainly because of blood clots and severe anemia. This is why rapid treatment is so decisive. (Older studies reported up to 50%.)

After successful treatment, most dogs do not relapse, but a risk of relapse remains (especially in the first year). Regular veterinary monitoring is essential to catch it early.

A personalized care plan, sometimes including consultation with an internal medicine specialist (veterinary internist), is often the best strategy for long-term IMHA management.

Home care

Home management tips

To implement

Administer all medications rigorously, at prescribed doses and times
Plan prescription refills in advance, never stop abruptly
Check gum color daily (pale pink or white = emergency)
Watch for signs of digestive bleeding: black or tarry stools, vomiting blood (a possible effect of steroids)
Watch for signs of infection (fever, lethargy): the treatment lowers immune defenses
Place non-slip surfaces (rugs) to prevent falls if the dog is weak
Install ramps or small steps if the dog has difficulty climbing up or down
Offer regular meals in small portions to monitor appetite
Monitor energy, thirst, appetite, and urine color every day
Minimize stress (avoid unnecessary travel, noisy environments)
Obtain a vaccination exemption letter if recommended by the veterinarian

Never do

Adjust immunosuppressant doses without veterinary guidance
Abruptly stop prednisone or any other immunosuppressant
Administer vaccines without prior discussion with the veterinarian
Give human anti-inflammatories or painkillers (aspirin, ibuprofen): combined with the cortisone, they can cause serious stomach ulcers

Always

Maintain regular veterinary follow-up with bloodwork
Report any signs of relapse immediately (paleness, weakness, jaundice)
Keep the vaccination exemption letter in the dog's medical file

FAQ

Frequently asked questions

IMHA: does my dog really make antibodies against itself?

Yes, exactly. In IMHA, the immune system, which normally protects against foreign invaders, malfunctions and produces antibodies that target the dog's own red blood cells. We don't always know why this dysregulation occurs. It may be triggered by an external factor (medication, infection, tumor) or occur without an identifiable cause (idiopathic form). Treatment aims to 'calm down' this overactive immune system.

Why does my dog need a blood transfusion?

In severe anemia, red blood cells are being destroyed too rapidly for the body to naturally replace them. The dog lacks oxygen in all its organs. A transfusion provides functional RBCs to stabilize the dog and 'buy time' while immunosuppressants begin to take effect (which typically takes several days). A transfusion doesn't treat the cause of IMHA; it stabilizes the emergency situation.

Are immunosuppressant medications dangerous?

Immunosuppressants (prednisone, azathioprine, cyclosporine) have real side effects. High-dose prednisone can cause increased thirst and urination, weight gain, increased susceptibility to infections, and, long-term, iatrogenic Cushing's syndrome. These effects are regularly monitored by your veterinarian. Gradual dose reduction once the disease stabilizes helps limit side effects. The benefit of stopping RBC destruction far outweighs the risks associated with treatment.

Will my dog be cured after treatment?

IMHA can enter complete remission in some dogs, but the risk of relapse persists for life. 'Cure' is not quite the right term; 'remission' is more accurate. Some dogs never relapse; others require repeated treatment cycles. Regular follow-up with periodic bloodwork is essential to detect any early relapse and intervene promptly.

Is it really necessary to avoid vaccines in the future?

Generally, yes, vaccines can potentially trigger a relapse in a dog that has suffered from IMHA. Your veterinarian can issue an official vaccination exemption letter, recognized by most kennels, shelters, and local regulations. Antibody titer testing can verify whether the dog still has adequate protection against certain diseases without needing a booster. Each decision should be made individually with your veterinarian based on the dog's risk profile.

Is your dog showing signs of IMHA?

IMHA requires prompt management. Our veterinary team is available to evaluate your dog and start appropriate treatment without delay.

Book an appointment(opens in a new tab)514 223-1197